Vertex Pharmaceuticals (VRTX) Free Cash Flow (2009 - 2026)
Vertex Pharmaceuticals (VRTX) free cash flow from Mar 31, 2009 to Mar 31, 2026. The TTM Vertex Pharmaceuticals (VRTX) free cash flow is $3.71B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Vertex Pharmaceuticals (VRTX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -1.57% |
| 5 Years TTM | +4.01% |
Annual Free Cash Flow change of Vertex Pharmaceuticals (VRTX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $1.29B | -59.46% |
| 2025 | $3.19B | -504.13% |
| 2024 | -$790M | -123.68% |
| 2023 | $3.34B | -14.99% |
| 2022 | $3.93B | +62.97% |
| 2021 | $2.41B | -19.55% |
| 2020 | $2.99B | +100.40% |
| 2019 | $1.49B | +27.16% |
| 2018 | $1.17B | +57.58% |
| 2017 | $746M | +315.24% |
| 2016 | $180M | -143.71% |
| 2015 | -$411M | -27.23% |
| 2014 | -$564M | +448.17% |
| 2013 | -$103M | -152.34% |
| 2012 | $197M | -147.05% |
| 2011 | -$418M | -37.92% |
| 2010 | -$673M | +49.30% |
| 2009 | -$451M | +74.39% |
| 2008 | -$259M | N/A |
Comparison Vertex Pharmaceuticals (VRTX) five years free cash flow CAGR with competitors
Vertex Pharmaceuticals (VRTX) five years free cash flow CAGR is 4.01%.